Osteoporosis in anorexia nervosa.

Area of Science:

• Pediatric Endocrinology
• Bone Metabolism
• Eating Disorders

Background:

• Anorexia nervosa (AN) is linked to decreased bone mass and increased fracture risk.
• Adolescence, a critical period for peak bone mass accrual, is the typical onset for AN.
• Multifactorial causes include poor nutrition, low body weight, hormonal deficiencies, and hypercortisolism.

Purpose of the Study:

• To review fracture risk assessment in pediatric AN.
• To summarize evidence on low bone mass and fracture risk in AN.
• To discuss management strategies for low bone mass in AN.

Main Methods:

• Literature review of recent recommendations for fracture risk assessment.
• Synthesis of evidence regarding bone density and fragility in AN.
• Discussion of therapeutic approaches for managing low bone mass.

Main Results:

• AN is associated with reduced bone formation and accelerated resorption, leading to low bone mass.
• Weight gain and hormonal normalization may partially improve bone mass but often not to normal levels.
• Oral estrogen therapy is ineffective; bisphosphonates show promise but have safety concerns.

Conclusions:

• Effective treatments for bone loss in AN are lacking.
• Bisphosphonates, alongside nutritional rehabilitation, may offer a potential therapeutic avenue.
• Further research is needed to optimize bone health management in AN patients.